Endomag’s mission is to improve the standard of cancer care for everyone, everywhere, by providing more accurate, convenient and less-expensive solutions for diagnosis and treatment.
The Company’s current focus is to improve breast cancer surgery. Research into breast cancer has made significant progress in recent years, meaning that, if caught early enough, 99% of patients are likely to be alive five years after diagnosis1, compared with just 40% in the 1970s2. Endomag is pioneering in these advancements, and its products have been used to successfully treat over 35,000 patients in over 30 countries worldwide.
Endomag has developed a minimally-invasive surgical guidance system, which can detect early-stage and impalpable tumors, and determine whether the cancer has spread to a patient’s lymph nodes. The system uses magnetic field technology, providing a safer, more comfortable and efficient option, over alternative techniques.